Published in Scand J Immunol on August 01, 1985
In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). J Exp Med (1988) 2.81
Rapid isolation of K88+ Escherichia coli by using immunomagnetic particles. J Clin Microbiol (1988) 1.66
Immunomagnetically captured thermophilic sulfate-reducing bacteria from north sea oil field waters. Appl Environ Microbiol (1992) 1.46
Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjögren's syndrome through fas-mediated apoptosis. Am J Pathol (1999) 1.11
Development of the immunomagnetic enrichment method selective for Vibrio parahaemolyticus serotype K and its application to food poisoning study. Appl Environ Microbiol (1992) 1.09
Rapid Immunocapture of Pseudomonas putida Cells from Lake Water by Using Bacterial Flagella. Appl Environ Microbiol (1991) 1.08
Immunomagnetic separation and DNA hybridization for detection of enterotoxigenic Escherichia coli in a piglet model. J Clin Microbiol (1991) 1.00
Allogeneic lymphocyte cytotoxicity (ALC) in rats: establishment of an in vitro assay, and direct evidence that cells with natural killer (NK) activity are involved in ALC. Immunology (1987) 0.99
Immobilization of polynucleotides on magnetic particles. Factors influencing hybridization efficiency. Biochem J (1991) 0.94
Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis. Am J Pathol (2000) 0.91
Evidence for circulating activated cytotoxic T cells in HIV-infected subjects before the onset of opportunistic infections. Clin Exp Immunol (1990) 0.90
Induction of stable chimerism and elimination of graft-versus-host disease by depletion of T lymphocytes from bone marrow using immunomagnetic beads. Surgery (1989) 0.85
Pulmonary alveolar macrophages from patients with active sarcoidosis express type IV collagenolytic proteinase. An enzymatic mechanism for influx of mononuclear phagocytes at sites of disease activity. J Clin Invest (1989) 0.81
CD3+ CD57+ lymphocytes are not likely to be involved in antigen-specific rejection processes in long-term allograft recipients. Clin Exp Immunol (1992) 0.81
Trisomy 7 and trisomy 10 characterize subpopulations of tumor-infiltrating lymphocytes in kidney tumors and in the surrounding kidney tissue. Proc Natl Acad Sci U S A (1992) 0.78
Magnetic microsphere-based methods to study the interaction of teicoplanin with peptides and bacteria. Anal Bioanal Chem (2008) 0.75
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 24.57
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet (2011) 10.62
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet (2011) 8.24
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet (2000) 7.19
Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med (1989) 4.30
Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database. BMJ (2009) 4.19
Impact of introducing near patient testing for standard investigations in general practice. BMJ (1993) 3.44
The use of air or CO2 as insufflation agents for double contrast barium enema (DCBE): is there a qualitative difference? Clin Radiol (1995) 3.22
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet (2008) 2.91
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr (2010) 2.91
Magnetic separation techniques in diagnostic microbiology. Clin Microbiol Rev (1994) 2.41
Self-cleaving viroid and newt RNAs may only be active as dimers. Nature (1988) 2.37
The imprinted antisense RNA at the Igf2r locus overlaps but does not imprint Mas1. Nat Genet (2000) 2.16
CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. Evidence for a soluble inhibitor. J Immunol (1990) 2.13
Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol (1985) 2.06
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet (2015) 2.05
Few infected CD4+ T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection. J Virol (1991) 2.05
Emergency response to raccoon rabies introduction into Ontario. J Wildl Dis (2001) 1.91
Effectiveness and cost of different strategies for information feedback in general practice. Br J Gen Pract (1994) 1.74
Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype. J Med Genet (2009) 1.74
Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma. Scand J Immunol (1985) 1.72
Aluminium in bone from patients with renal failure. Br Med J (1971) 1.70
HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique. Tissue Antigens (1986) 1.67
Binge drinking, sexual behaviour and sexually transmitted infection in the UK. Int J STD AIDS (2007) 1.67
Rapid isolation of K88+ Escherichia coli by using immunomagnetic particles. J Clin Microbiol (1988) 1.66
Expression of anthocyanin biosynthesis pathway genes in red and white grapes. Plant Mol Biol (1996) 1.65
ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre. Eur Respir J (2011) 1.61
Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex. Science (1994) 1.59
Cell-to-cell movement of potato virus X is associated with a change in the size-exclusion limit of plasmodesmata in trichome cells of Nicotiana clevelandii. Virology (1996) 1.56
Crystal structure of prokaryotic ribosomal protein L9: a bi-lobed RNA-binding protein. EMBO J (1994) 1.52
Randomized clinical trial comparing day-care open haemorrhoidectomy under local versus general anaesthesia. Br J Surg (2008) 1.50
The trials of Dr. Bernard Fisher: a European perspective on an American episode. Control Clin Trials (1997) 1.49
Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens (2004) 1.47
Addition of rosiglitazone to existing sulfonylurea treatment in chinese patients with type 2 diabetes and exposure to hepatitis B or C. Diabetes Technol Ther (2003) 1.46
Propofol and excitatory sequelae in dogs. Anaesthesia (1991) 1.45
Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact? Diabet Med (2013) 1.42
Joint estimation of Down syndrome risk and ascertainment rates: a meta-analysis of nine published data sets. Prenat Diagn (1998) 1.41
Plight of Afghan people must not be forgotten. BMJ (2001) 1.41
Isolation of pure functionally active CD8+ T cells. Positive selection with monoclonal antibodies directly conjugated to monosized magnetic microspheres. J Immunol Methods (1986) 1.38
Getting health professionals to work together. BMJ (2000) 1.37
Cyclic AMP-dependent protein kinase type I mediates the inhibitory effects of 3',5'-cyclic adenosine monophosphate on cell replication in human T lymphocytes. J Biol Chem (1992) 1.37
CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily. Mol Cell Biol (2000) 1.35
Charcot neuroarthropathy in diabetes mellitus. Diabetologia (2002) 1.35
Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas (2013) 1.34
Quality improvement in general practice. Br J Gen Pract (1997) 1.33
An evaluation of hospital cleaning regimes and standards. J Hosp Infect (2000) 1.32
Is normal pregnancy atherogenic? Clin Sci (Lond) (1999) 1.31
Functional characterization of human nucleosome assembly protein-2 (NAP1L4) suggests a role as a histone chaperone. Genomics (1997) 1.28
Direct immunomagnetic quantification of lymphocyte subsets in blood. Clin Exp Immunol (1988) 1.24
Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet (1984) 1.22
Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry (2009) 1.22
Identification of a putative motif for binding of peptides to HLA-DQ2. Int Immunol (1996) 1.22
Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex. Arthritis Rheum (1986) 1.20
Depletion of T lymphocytes from human bone marrow. Use of magnetic monosized polymer microspheres coated with T-lymphocyte-specific monoclonal antibodies. Transplantation (1987) 1.20
Neurosyphilis: intrathecal synthesis of oligoclonal antibodies to Treponema pallidum. Ann Neurol (1982) 1.19
The efficacy of indoor CDC light traps for collecting the sandfly Phlebotomus argentipes, vector of Leishmania donovani. Med Vet Entomol (2008) 1.19
Case-control study of GP attendance rates by suicide cases with or without a psychiatric history. Br J Gen Pract (1997) 1.18
Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. Proc Natl Acad Sci U S A (2000) 1.17
In situ characterization of mononuclear cells in rheumatoid tissues, using monoclonal antibodies. No reduction of T8-positive cells or augmentation in T4-positive cells. Scand J Immunol (1982) 1.17
HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum Immunol (1992) 1.17
Viral and bacterial antibody responses in multiple sclerosis. Ann Neurol (1980) 1.17
Shared idiotypes of human peripheral blood B and T lymphocytes. J Immunol (1979) 1.16
Expression patterns of cell wall-modifying enzymes during grape berry development. Planta (2001) 1.16
Junior doctors' hours. Committee lacks "shop floor" support. BMJ (1995) 1.15
Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3. Scand J Immunol (1988) 1.15
Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC). Clin Exp Immunol (1993) 1.15
A 1-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPA1 and the BWSCR1/WT2 region. Genomics (1997) 1.12
Distribution of HLA class II alleles among Norwegian Caucasians. Hum Immunol (1990) 1.12
Immunoisolation using magnetic solid supports: subcellular fractionation for cell-free functional studies. Methods Cell Biol (1989) 1.11
Variation in use of adjuvant tamoxifen. Lancet (1998) 1.11
Characterization of human mononuclear cells after positive selection with immunomagnetic particles. Scand J Immunol (1986) 1.11
Molecular cloning of a T cell-specific adapter protein (TSAd) containing an Src homology (SH) 2 domain and putative SH3 and phosphotyrosine binding sites. J Biol Chem (1998) 1.11
Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens (1991) 1.11
Structure of lipid tubules formed from a polymerizable lecithin. Biophys J (1985) 1.11
The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. Genes Immun (2001) 1.11
Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia (2008) 1.10
Tamoxifen for early breast cancer: better late than never. Ann Oncol (2000) 1.10
T lymphocyte subset changes in human immunodeficiency virus infection. J Acquir Immune Defic Syndr (1989) 1.09
Neural and humoral mechanisms involved in blood pressure variability. J Hypertens (1984) 1.09
Mumps meningitis: specific and non-specific antibody responses in the central nervous system. Acta Neurol Scand (1982) 1.09
Imprint immunofixation of electrofocused immunoglobulins. J Immunol Methods (1983) 1.08
Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer. Breast Cancer Res Treat (2011) 1.07
Multiple sclerosis. Electrofocused "bands" of oligoclonal CSF IgG do not carry antibody activity against measles, varicella-zoster or rotaviruses. J Neurol Sci (1982) 1.07
Near patient testing in general practice: attitudes of general practitioners and practice nurses, and quality assurance procedures carried out. Br J Gen Pract (1994) 1.06
A comparison of the anthropometric, strength, endurance and flexibility characteristics of female elite and recreational climbers and non-climbers. J Sports Sci (2001) 1.06
Multiple sclerosis: subclasses of intrathecally synthesized IgG and measles and varicella zoster virus IgG antibodies. Clin Exp Immunol (1983) 1.05
The crystal structure of human phosphoglucose isomerase at 1.6 A resolution: implications for catalytic mechanism, cytokine activity and haemolytic anaemia. J Mol Biol (2001) 1.05
Ribosomal protein L9: a structure determination by the combined use of X-ray crystallography and NMR spectroscopy. J Mol Biol (1996) 1.05
Molecular basis of neurological dysfunction coupled with haemolytic anaemia in human glucose-6-phosphate isomerase (GPI) deficiency. Hum Genet (1998) 1.04
Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis. J Neurol Sci (2000) 1.03
Nasal carriage in Vietnamese children of Streptococcus pneumoniae resistant to multiple antimicrobial agents. Antimicrob Agents Chemother (2000) 1.03